General
Pfizer says trials show COVID-19 antiviral pill cuts hospitalisation and death risk by nearly 90 per cent
Pfizer says its experimental antiviral pill for COVID-19 cut rates of hospitalisation and death by nearly 90 per cent in high-risk adults, as the drugmaker joined the race for an easy-to-use medication to treat the coronavirus.
Key points:
- Pfizer says preliminary results of its study show its…
Continue Reading
-
Noosa News20 hours agoElderly pair killed in rural highway intersection crash with caravan
-
Noosa News13 hours agoBrisbane community mourns 14-year-old Declan Phillips after deadly Wynnum crash
-
Business20 hours ago3 of the best ASX shares to buy with $5,000
-
General13 hours agoThe wrong way to respond to antisemitism • Inside Story